HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.
Los Angelas, CA -- (SBWIRE) -- 10/19/2012 -- MannKind Corporation ( NASDAQ:MNKD) recently announced that it will be looking to offer and sell shares of its common stock and warrants to purchase shares of its common stock in an underwritten public offering. MannKind did not mention the size and terms of the offering. MannKind also plans to issue to The Mann Group LLC restricted shares and warrants to purchase shares of its common stock. MannKind Corporat (NGM:MNKD) reported EPS of -1.093. For the Current Fiscal year, the company is expected to report EPS of -0.92. For the Next Quarter and Next Year, the company is expected to report EPS of -0.20 and -0.47 respectively. At Current Market Price, MNKD is in distance of -25.48% from its 50-day Moving Average price of $2.6434 and -14.62% from its 200-day Moving Average price of $2.3074. Aditionally There can be no assurance as to whether or when the offering may be completed. Jefferies & Company Incand Piper Jaffray& Co are acting as joint book-running managers for the offering.
Can MNKD Bounce Back From Here or Going Down : CHECK HERE
Mellanox Technolo (NasdaqNM:MLNX) are trading at $77.988 and is -25.52% from its 50-day Moving Average price of $104.703 and -3.51% from its 200-day Moving Average price of $80.8257. The average trading volume is 1365120 shares and its market capitalization is $3.243B. Mellanox Technologies Ltd (NASDAQ:MLNX) declined 19.33% to $79.18 on a traded volume of 3.04 million shares.The Company reported revenue of $156.5 million versus $68.2 million in the third quarter of 2011. GAAP gross margins in the third quarter of 2012 were 69.1% compared to64.5% in the third quarter of 2011. GAAP net income was $48.4 million or $1.09 per diluted share compared to net income of $4.8 million or $0.13 per diluted share in the third quarter of 2011. Total cash and investments were $405.4 million at September 30, 2012.
How Should Investors React To MLNX Now? Find Out Here
Align Technology, (NasdaqNM:ALGN) are trading at $28.18 and is -23.71% from its 50-day Moving Average price of $36.9369 and -14.91% from its 200-day Moving Average price of $33.1176. The average trading volume is 1446340 shares and its market capitalization is $2.292B. Align Technology, Inc.(NASDAQ:ALGN) reported preliminary third-quarter net income of $24 million or $0.29 per share, as compared with $19 million or $0.24 per share in the same quarter last year. Adjusted earnings for the quarter were $23.7 million or $0.28 per share, compared with $22 million or $0.27 per share last year. Analysts expected earnings of $0.29 per share for the quarter. Net revenues were $136.5 million, up from $126 million in the prior year. Analysts on consensus expected revenues of $140.14 million. The shares of the company fell 7.47% and closed at $35.41 in the last trading session.
Don’t Forget To Sign Up For Free Trend Analysis on ALGN Here
ImmunoCellular Th (AMEX:IMUC) are trading at $2.07 and is -26.37% from its 50-day Moving Average price of $2.8114 and -30.97% from its 200-day Moving Average price of $2.9987. The average trading volume is 634275 shares and its market capitalization is $84.1M. ImmunoCellular Therapeutics Ltd(NYSEAMEX: IMUC) moved down 14.94% to $2.05 on a traded volume of 2.43 million shares.The Company announced the pricing of 10 million shares at a 13% discount to Wednesday’s close. The Company also is offering warrants to purchase as many as 4.5 million additional shares. The Company intends to use proceeds for the continuing clinical development of its brain cancer treatment and lead pipeline productand for general corporate purposes.
Find Out If IMUC Maintain The Momentum : CHECK HERE
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to loose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)